. 2023 Jun 21;7(4):100193.

doi: 10.1016/j.rpth.2023.100193. eCollection 2023 May.

Illustrated State-of-the-Art Capsules of the ISTH 2023 Congress

Susan R Kahn¹, Donald M Arnold², Caterina Casari³, Karl C Desch⁴, Katrien M J Devreese⁵, Emmanuel J Favaloro⁶, Florian Gaertner⁷, Samantha C Gouw⁸, Paolo Gresele⁹, Arjan W Griffioen¹⁰, Lukas Heger^{11

12

13}, R Manjunatha Kini¹⁴, Shrey Kohli¹⁵, Avi Leader¹⁶, Ton Lisman¹⁷, Marie Lordkipanidzé¹⁸, Eric Mullins^{19

20}, Helen Chioma Okoye²¹, Rachel P Rosovsky²², Isabelle I Salles-Crawley²³, Rita Selby²⁴, Michelle Sholzberg²⁵, David Stegner²⁶, Francesco Violi²⁷, Angela C Weyand²⁸, Suzan Williams²⁹, Ze Zheng^{30

31}

Affiliations

¹ Medicine, Sir Mortimer B Davis Jewish General Hospital, McGill University, 3755 Cote Ste Catherine, Montreal, Quebec.
² Department of Medicine, McMaster University, Hamilton, ON, Canada.
³ Université Paris-Saclay, INSERM, Hémostase inflammation thrombose HITH U1176, 94276, Le Kremlin-Bicêtre, France.
⁴ Cell and Molecular Biology Program, University of Michigan, Ann Arbor, USA.
⁵ Coagulation Laboratory, Department of Laboratory Medicine, Ghent University Hospital, Department of Diagnostic Sciences, Ghent University, Ghent, Belgium.
⁶ Haematology, Sydney Centres for Thrombosis and Haemostasis, Institute of Clinical Pathology and Medical Research (ICPMR), NSW Health Pathology, Westmead Hospital, Westmead, NSW Australia.
⁷ Technische Universität München (TUM), Ismaninger Straße 22, München, Bayern 81675, Germany.
⁸ Amsterdam UMC location University of Amsterdam, Department of Pediatric Hematology, Meibergdreef 9, Amsterdam, The Netherlands.
⁹ University of Perugia, Department of Medicine and Surgery, Head Section of Internal and Cardiovascular Medicine.
¹⁰ Angiogenesis Laboratory, Department of Medical Oncology, Amsterdam UMC, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, The Netherlands.
¹¹ Department of Pediatrics, Harvard Medical School, Boston, MA 02115, USA; Program in Cellular and Molecular Medicine, Boston Children's Hospital, Boston, MA 02115, USA; Departement of Cardiology and Angiology, University Hospital Freiburg Bad Krozingen, 79106 Freiburg, Germany.
¹² Program in Cellular and Molecular Medicine, Boston Children's Hospital, Boston, MA 02115, USA.
¹³ Departement of Cardiology and Angiology, University Hospital Freiburg Bad Krozingen, 79106 Freiburg, Germany.
¹⁴ National University of Singapore, Singapore.
¹⁵ Institute of Laboratory Medicine, Clinical Chemistry and Molecular Diagnostics, Universitätsklinikum Leipzig, Leipzig University, 04103 Leipzig, Germany.
¹⁶ Institute of Hematology, Davidoff Cancer Center, Rabin Medical Center, Petah Tikva, Israel and Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
¹⁷ Surgical Research Laboratory and Section of Hepatobiliary Surgery and Liver Transplantation, Department of Surgery, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.
¹⁸ Faculty of pharmacy, University of Montreal.
¹⁹ Division of Hematology, Cancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.
²⁰ University of Cincinnati - College of Medicine, Cincinnati, OH, USA.
²¹ College of Medicine, University of Nigeria, Ituku Ozalla campus, Enugu Nigeria.
²² Massachusetts General Hospital.
²³ St George's University of London.
²⁴ Departments of Laboratory Medicine & Pathobiology and Department of Medicine, University of Toronto.
²⁵ St. Michael's Hospital, University of Toronto.
²⁶ Julius-Maximilians-Universität Würzburg.
²⁷ Department of Clinical, Internal Medicine, Anesthesiological and Cardiovascular Sciences, Sapienza University of Rome, Rome, Italy.
²⁸ Department of Pediatrics, University of Michigan Medical School.
²⁹ Hospital for Sick Children, University of Toronto.
³⁰ Medical College of Wisconsin, Milwaukee, Wisconsin 53226, USA.
³¹ Versiti Blood Research Institute, Milwaukee, Wisconsin 53226, USA.

PMID: 37538494
PMCID: PMC10394567
DOI: 10.1016/j.rpth.2023.100193

Illustrated State-of-the-Art Capsules of the ISTH 2023 Congress

Susan R Kahn et al. Res Pract Thromb Haemost. 2023.

. 2023 Jun 21;7(4):100193.

doi: 10.1016/j.rpth.2023.100193. eCollection 2023 May.

Authors

Affiliations

¹ Medicine, Sir Mortimer B Davis Jewish General Hospital, McGill University, 3755 Cote Ste Catherine, Montreal, Quebec.
² Department of Medicine, McMaster University, Hamilton, ON, Canada.
³ Université Paris-Saclay, INSERM, Hémostase inflammation thrombose HITH U1176, 94276, Le Kremlin-Bicêtre, France.
⁴ Cell and Molecular Biology Program, University of Michigan, Ann Arbor, USA.
⁵ Coagulation Laboratory, Department of Laboratory Medicine, Ghent University Hospital, Department of Diagnostic Sciences, Ghent University, Ghent, Belgium.
⁶ Haematology, Sydney Centres for Thrombosis and Haemostasis, Institute of Clinical Pathology and Medical Research (ICPMR), NSW Health Pathology, Westmead Hospital, Westmead, NSW Australia.
⁷ Technische Universität München (TUM), Ismaninger Straße 22, München, Bayern 81675, Germany.
⁸ Amsterdam UMC location University of Amsterdam, Department of Pediatric Hematology, Meibergdreef 9, Amsterdam, The Netherlands.
⁹ University of Perugia, Department of Medicine and Surgery, Head Section of Internal and Cardiovascular Medicine.
¹⁰ Angiogenesis Laboratory, Department of Medical Oncology, Amsterdam UMC, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, The Netherlands.
¹¹ Department of Pediatrics, Harvard Medical School, Boston, MA 02115, USA; Program in Cellular and Molecular Medicine, Boston Children's Hospital, Boston, MA 02115, USA; Departement of Cardiology and Angiology, University Hospital Freiburg Bad Krozingen, 79106 Freiburg, Germany.
¹² Program in Cellular and Molecular Medicine, Boston Children's Hospital, Boston, MA 02115, USA.
¹³ Departement of Cardiology and Angiology, University Hospital Freiburg Bad Krozingen, 79106 Freiburg, Germany.
¹⁴ National University of Singapore, Singapore.
¹⁵ Institute of Laboratory Medicine, Clinical Chemistry and Molecular Diagnostics, Universitätsklinikum Leipzig, Leipzig University, 04103 Leipzig, Germany.
¹⁶ Institute of Hematology, Davidoff Cancer Center, Rabin Medical Center, Petah Tikva, Israel and Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
¹⁷ Surgical Research Laboratory and Section of Hepatobiliary Surgery and Liver Transplantation, Department of Surgery, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.
¹⁸ Faculty of pharmacy, University of Montreal.
¹⁹ Division of Hematology, Cancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.
²⁰ University of Cincinnati - College of Medicine, Cincinnati, OH, USA.
²¹ College of Medicine, University of Nigeria, Ituku Ozalla campus, Enugu Nigeria.
²² Massachusetts General Hospital.
²³ St George's University of London.
²⁴ Departments of Laboratory Medicine & Pathobiology and Department of Medicine, University of Toronto.
²⁵ St. Michael's Hospital, University of Toronto.
²⁶ Julius-Maximilians-Universität Würzburg.
²⁷ Department of Clinical, Internal Medicine, Anesthesiological and Cardiovascular Sciences, Sapienza University of Rome, Rome, Italy.
²⁸ Department of Pediatrics, University of Michigan Medical School.
²⁹ Hospital for Sick Children, University of Toronto.
³⁰ Medical College of Wisconsin, Milwaukee, Wisconsin 53226, USA.
³¹ Versiti Blood Research Institute, Milwaukee, Wisconsin 53226, USA.

PMID: 37538494
PMCID: PMC10394567
DOI: 10.1016/j.rpth.2023.100193

Abstract

This year's Congress of the International Society of Thrombosis and Haemostasis (ISTH) took place in person in Montréal, Canada, from June 24-28, 2023. The conference, held annually, highlighted cutting-edge advances in basic, translational, population and clinical sciences relevant to the Society. As for all ISTH congresses, we offered a special, congress-specific scientific theme; this year, the special theme was immunothrombosis. Certainly, over the last few years, COVID-19 infection and its related thrombotic and other complications have renewed interest in the concepts of thromboinflammation and immunothrombosis; namely, the relationship between inflammation, infection and clotting. Other main scientific themes of the Congress included Arterial Thromboembolism, Coagulation and Natural Anticoagulants, Diagnostics and Omics, Fibrinolysis and Proteolysis, Hemophilia and Rare Bleeding Disorders, Hemostatic System in Cancer, Inflammation and Immunity, Pediatrics, Platelet Disorders, von Willebrand Disease and Thrombotic Microangiopathies, Platelets and Megakaryocytes, Vascular Biology, Venous Thromboembolism and Women's Health. Among other sessions, the program included 28 State-of-the-Art (SOA) sessions with a total of 84 talks given by internationally recognized leaders in the field. SOA speakers were invited to prepare brief illustrated reviews of their talks that were peer reviewed and are included in this article. These illustrated capsules highlight the major scientific advances with potential to impact clinical practice. Readers are invited to take advantage of the excellent educational resource provided by these illustrated capsules. They are also encouraged to use the image in social media to draw attention to the high quality and impact of the science presented at the Congress.

PubMed Disclaimer

Figures

See this image and copyright information in PMC

References

1. Kelton J.G., Arnold D.M., Nazy I. Lessons from vaccine-induced immune thrombotic thrombocytopenia. Nat Rev Immunol. 2021 Dec;21(12):753–755. - PMC - PubMed
1. Arnold D.M., Kelton J.G. Current options for the treatment of idiopathic thrombocytopenic purpura. Semin Hematol. 2007 Oct;44(4 Suppl 5):S12–23. - PubMed
1. Denis C.V., Susen S., Lenting P.J. von Willebrand disease: what does the future hold? Blood. 2021;137:2299–2306. - PubMed
1. Kovacevic K.D., Grafeneder J., Schörgenhofer C., Gelbenegger G., Gager G., Firbas C., Quehenberger P., Jilma-Stohlawetz P., Bileck A., Zhu S., Gilbert J.C., Beliveau M., Jilma B., Derhaschnig U. The von Willebrand factor A-1 domain binding aptamer BT200 elevates plasma levels of von Willebrand factor and factor VIII: a first-in-human trial. Haematol. 2021;107:2121–2132. - PMC - PubMed
1. Weyand A.C., Flood V.H., Shavit J.A., Pipe S.W. Efficacy of emicizumab in a pediatric patient with type 3 von Willebrand disease and alloantibodies. Blood Adv. 2019;3:2748–2750. - PMC - PubMed

LinkOut - more resources

Full Text Sources
Research Materials
- NCI CPTC Antibody Characterization Program

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Illustrated State-of-the-Art Capsules of the ISTH 2023 Congress

Affiliations

Illustrated State-of-the-Art Capsules of the ISTH 2023 Congress

Authors

Affiliations

Abstract

Figures

References

LinkOut - more resources

Full Text Sources

Research Materials